Budimir S. Drakulic
Directeur Technique/Scientifique/R&D chez BIOSIG TECHNOLOGIES, INC.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Frederick Hrkac | M | 58 | 2 ans | |
Lora Mikolaitis | F | 51 | 15 ans | |
Steven Abelman | M | - | - | |
Zachary Koch | M | - | 2 ans | |
Ewald Riechert | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jeffrey O'Donnell | M | 64 | 10 ans | |
Kenneth Londoner | M | 57 | 15 ans | |
Greg Cash | M | 66 | 3 ans | |
Marvin Fink | M | 88 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 3 ans |
David J. Drachman | M | 66 | - | |
Donald Foley | M | 73 | 9 ans | |
Tiffini Wittwer | F | - | - | |
Natasha Drapeau | F | - | 5 ans | |
Anthony Zook | M | 63 | 2 ans | |
Jerome Zeldis | M | 74 | 1 ans | |
James Barry | M | 64 | 3 ans | |
Patrick Gallagher | M | 59 | 10 ans | |
Andrew Filler | M | 56 | 4 ans | |
Jonathan Steinhouse | M | 57 | - | |
Roy Tanaka | M | 75 | 7 ans | |
William Uglow | M | 76 | - | |
Pamela M. Bunes | F | 61 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 ans |
Lowell T. Harmison | M | 87 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
James Klein | M | 59 | 2 ans | |
Steven Chaussy | M | 70 | 12 ans | |
Asher Holzer | M | 74 | - | |
Samuel Navarro | M | 68 | 3 ans | |
David Weild | M | 67 | 9 ans | |
Kalyanam Shivkumar | M | 56 | 2 ans | |
Martha Pease | F | 66 | 2 ans | |
Brian McLaughlin | M | - | - | |
John Sieckhaus | M | 56 | 2 ans | |
Gray Fleming | M | 47 | 3 ans | |
John Kowalski | M | - | 2 ans | |
Andrew Gornell Ballou | M | - | 5 ans | |
Julie Stephenson | F | - | - | |
Olivier Chaudoir | M | - | 3 ans | |
MaryAnn Edzards | F | - | 2 ans | |
Manasi Patwardhan | F | - | 3 ans | |
Barry Keenan | M | - | 2 ans | |
Charles H. Harrison | M | 81 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 ans |
Jay Millerhagen | M | - | 2 ans | |
Robert G. Koblin | M | 92 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 ans |
Steven Creviston | M | 60 |
Teledyne Electronic Technologies
| 7 ans |
Robert C. Scherne | M | 67 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Jay A. Johnson | M | 63 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 1 ans |
Steven Buhaly | M | 67 | 1 ans | |
Ellsworth Roston | M | 101 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 7 ans |
Jennifer Black | F | 68 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 6 ans |
William Robert Matthews | M | 69 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 5 ans |
Sasha Gentling | F | - | 3 ans | |
Seth Fischer | M | 68 | 6 ans | |
Rodney Hildebrandt | M | - |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 1 ans |
Norma Provencio | F | 67 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Kevin F. Pickard | M | 59 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 3 ans |
Brenda Castrodad | F | - | 2 ans | |
Joseph Rafferty | M | 66 | - | |
Katie Freshwater | F | - | 1 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 58 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Budimir S. Drakulic
- Réseau Personnel